We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Value of High-Dose Cytarabine During Interval Therapy of a Berlin-Frankfurt-Munster–Based Protocol in Increased-Risk Children With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Results of the European Organization for Research and Treatment of Cancer 58881 Randomized Phase III Trial
- Authors
Millot, F.; Suciu, S.; Philippe, N.; Benoit, Y.; Mazingue, F.; Uyttebroeck, A.; Lutz, P.; Mechinaud, F.; Robert, A.; Boutard, P.; Marguerite, G.; Ferster, A.; Plouvier, E.; Rialland, X.; Behard, C.; Plantaz, D.; Dresse, M. F.; Philippet, P.; Norton, L.; Thyss, A.; Dastugue, N.; Waterkeyn, C.; Vilmer, E.; Otten, J.; for the Children’s Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer
- Publication
Journal of Clinical Oncology, 2001, Vol 19, Issue 7, p1935
- ISSN
0732-183x
- Publication type
article
- DOI
10.1200/jco.2001.19.7.1935